Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Curcuminoids, the active compounds found in turmeric (Curcuma longa), have been investigated for their potential benefits in managing eczema due to their anti-inflammatory and antioxidant properties. Several small-scale studies and preclinical trials suggest that curcuminoids may help reduce inflammation and oxidative stress, both of which play roles in the pathogenesis of eczema (atopic dermatitis). For example, some clinical trials have evaluated topically applied curcumin formulations and found modest improvements in eczema symptoms compared to placebo. Animal studies also indicate that curcuminoids can modulate inflammatory cytokines and improve skin barrier function. However, the quality and sample size of human studies are generally limited, and there is a lack of large, well-controlled clinical trials to provide robust evidence for the regular use of curcuminoids in eczema management.

Traditionally, turmeric has been used in various cultures for skin health, including the treatment of inflammatory skin conditions, but the modern evidence base specifically for eczema remains preliminary. Systematic reviews and dermatology guidelines currently do not recommend curcuminoids as a first-line or established adjunct therapy for eczema, highlighting the need for more rigorous research. Overall, while there is some scientific rationale and early evidence for the use of curcuminoids in eczema, the current evidence is limited and rated as low to moderate (2/5) in terms of strength and reliability.

More about Curcuminoids
More about Eczema

Other ingredients used for Eczema

Other health conditions supported by Curcuminoids

Products containing Curcuminoids